Back to Search
Start Over
Apolipoprotein E4 and Alzheimer's disease causality under adverse environments and potential intervention by senolytic nutrients.
- Source :
-
Clinical nutrition ESPEN [Clin Nutr ESPEN] 2024 Sep 07; Vol. 64, pp. 16-20. Date of Electronic Publication: 2024 Sep 07. - Publication Year :
- 2024
- Publisher :
- Ahead of Print
-
Abstract
- Apolipoprotein E (apoE) has a pivotal role in Alzheimer's Disease (AD) pathophysiology. APOE4 has been recognized as a risk factor for developing late-onset AD. Recently, APOE4 homozygosity was regarded as a new familial genetic trait of AD. In this opinion paper, we summarized the potential pleiotropic antagonism role of APOE4 in children living under early life adversity and afflicted with enteric infection/malnutrition-related pathogenic exposome. APOE4 was found to be neuroprotective early in life despite its increasing risk for AD with aging. We call for awareness of the potential burden this can bring to the public health system when APOE4 carriers, raised under adverse environmental conditions in early life and then aging with unhealthy lifestyles in later life may be at special risk for cognitive impairments and acquired AD. We postulate the importance of anti-senescence therapies to protect these individuals and remediate aging-related chronic illnesses.<br />Competing Interests: Declaration of competing interest The authors declare no competing interests. MPV is a principal in Cognosci Inc., which has ownership rights to selected ApoE-mimetic peptides.<br /> (Copyright © 2024. Published by Elsevier Ltd.)
Details
- Language :
- English
- ISSN :
- 2405-4577
- Volume :
- 64
- Database :
- MEDLINE
- Journal :
- Clinical nutrition ESPEN
- Publication Type :
- Academic Journal
- Accession number :
- 39251089
- Full Text :
- https://doi.org/10.1016/j.clnesp.2024.09.004